Clinical Trial Update: Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) [Phase 3]

View source ↗

Summary

A phase 3 trial comparing standard CHOP to biweekly CHOP in aggressive non-Hodgkin's lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: Japan Clinical Oncology Group | Conditions: Non-Hodgkin's Lymphoma | Phase 3 | Status: TERMINATED